These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 26679242)

  • 1. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
    Farrag MA; Almajhdi FN
    Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.
    Rey-Jurado E; Soto J; Gálvez N; Kalergis AM
    Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.
    Rey-Jurado E; Kalergis AM
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of immature and senescent immune responses for infection with respiratory syncytial virus.
    Malloy AM; Falsey AR; Ruckwardt TJ
    Curr Top Microbiol Immunol; 2013; 372():211-31. PubMed ID: 24362692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.
    Andrade CA; Pacheco GA; Gálvez NMS; Soto JA; Bueno SM; Kalergis AM
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32545470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of host adaptive immunity by hRSV proteins.
    Espinoza JA; Bohmwald K; Céspedes PF; Riedel CA; Bueno SM; Kalergis AM
    Virulence; 2014; 5(7):740-51. PubMed ID: 25513775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.
    Gálvez NMS; Soto JA; Kalergis AM
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis.
    Piedra FA; Mei M; Avadhanula V; Mehta R; Aideyan L; Garofalo RP; Piedra PA
    PLoS One; 2017; 12(3):e0172953. PubMed ID: 28267794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cell immunity against human respiratory syncytial virus.
    Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
    Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of antibody against contemporary virus lineages of human respiratory syncytial virus sub-group A in infants and their mothers.
    McGill A; Greensill J; Craft AW; Fenwick F; Toms GL
    J Clin Virol; 2004 May; 30(1):73-80. PubMed ID: 15072758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
    Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
    Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
    Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
    J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
    Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
    Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection.
    Bohmwald K; Gálvez NMS; Canedo-Marroquín G; Pizarro-Ortega MS; Andrade-Parra C; Gómez-Santander F; Kalergis AM
    Front Immunol; 2019; 10():452. PubMed ID: 30936869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.
    Johnson TR
    Expert Rev Vaccines; 2006 Jun; 5(3):371-80. PubMed ID: 16827621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.
    Schepens B; Sedeyn K; Vande Ginste L; De Baets S; Schotsaert M; Roose K; Houspie L; Van Ranst M; Gilbert B; van Rooijen N; Fiers W; Piedra P; Saelens X
    EMBO Mol Med; 2014 Nov; 6(11):1436-54. PubMed ID: 25298406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.